Back to Search Start Over

Diagnostic Accuracy of Amyloid versus 18 F-Fluorodeoxyglucose Positron Emission Tomography in Autopsy-Confirmed Dementia.

Authors :
Lesman-Segev, Orit H
Lesman-Segev, Orit H
La Joie, Renaud
Iaccarino, Leonardo
Lobach, Iryna
Rosen, Howard J
Seo, Sang Won
Janabi, Mustafa
Baker, Suzanne L
Edwards, Lauren
Pham, Julie
Olichney, John
Boxer, Adam
Huang, Eric
Gorno-Tempini, Marilu
DeCarli, Charles
Hepker, Mackenzie
Hwang, Ji-Hye L
Miller, Bruce L
Spina, Salvatore
Grinberg, Lea T
Seeley, William W
Jagust, William J
Rabinovici, Gil D
Lesman-Segev, Orit H
Lesman-Segev, Orit H
La Joie, Renaud
Iaccarino, Leonardo
Lobach, Iryna
Rosen, Howard J
Seo, Sang Won
Janabi, Mustafa
Baker, Suzanne L
Edwards, Lauren
Pham, Julie
Olichney, John
Boxer, Adam
Huang, Eric
Gorno-Tempini, Marilu
DeCarli, Charles
Hepker, Mackenzie
Hwang, Ji-Hye L
Miller, Bruce L
Spina, Salvatore
Grinberg, Lea T
Seeley, William W
Jagust, William J
Rabinovici, Gil D
Source :
Annals of neurology; vol 89, iss 2, 389-401; 0364-5134
Publication Year :
2021

Abstract

ObjectiveThe purpose of this study was to compare the diagnostic accuracy of antemortem 11 C-Pittsburgh compound B (PIB) and 18 F-fluorodeoxyglucose (FDG) positron emission tomography (PET) versus autopsy diagnosis in a heterogenous sample of patients.MethodsOne hundred one participants underwent PIB and FDG PET during life and neuropathological assessment. PET scans were visually interpreted by 3 raters blinded to clinical information. PIB PET was rated as positive or negative for cortical retention, whereas FDG scans were read as showing an Alzheimer disease (AD) or non-AD pattern. Neuropathological diagnoses were assigned using research criteria. Majority visual reads were compared to intermediate-high AD neuropathological change (ADNC).ResultsOne hundred one participants were included (mean age = 67.2 years, 41 females, Mini-Mental State Examination = 21.9, PET-to-autopsy interval = 4.4 years). At autopsy, 32 patients showed primary AD, 56 showed non-AD neuropathology (primarily frontotemporal lobar degeneration [FTLD]), and 13 showed mixed AD/FTLD pathology. PIB showed higher sensitivity than FDG for detecting intermediate-high ADNC (96%, 95% confidence interval [CI] = 89-100% vs 80%, 95% CI = 68-92%, p = 0.02), but equivalent specificity (86%, 95% CI = 76-95% vs 84%, 95% CI = 74-93%, p = 0.80). In patients with congruent PIB and FDG reads (77/101), combined sensitivity was 97% (95% CI = 92-100%) and specificity was 98% (95% CI = 93-100%). Nine of 24 patients with incongruent reads were found to have co-occurrence of AD and non-AD pathologies.InterpretationIn our sample enriched for younger onset cognitive impairment, PIB-PET had higher sensitivity than FDG-PET for intermediate-high ADNC, with similar specificity. When both modalities are congruent, sensitivity and specificity approach 100%, whereas mixed pathology should be considered when PIB and FDG are incongruent. ANN NEUROL 2021;89:389-401.

Details

Database :
OAIster
Journal :
Annals of neurology; vol 89, iss 2, 389-401; 0364-5134
Notes :
application/pdf, Annals of neurology vol 89, iss 2, 389-401 0364-5134
Publication Type :
Electronic Resource
Accession number :
edsoai.on1287297950
Document Type :
Electronic Resource